Global Erectile Dysfunction Drugs Market Research Report 2023 and 2024-2034: Regulatory Approvals Boost Market Prospects, Viagra Dominates, Research and Development Activities Surge
15 janv. 2024 10h18 HE
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Global Erectile Dysfunction Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
Signati™ Medical, Inc. Receives FDA Approval for IDE Study
20 déc. 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The FDA has officially approved Signati™ Medical’s Investigational Device Exemption (IDE) study! This comes on the company’s 5 year anniversary....
Signati Medical™ Receives Additional Patent Protection for its Innovative Bipolar Handpiece
28 sept. 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Signati Medical™ is pleased to announce the issue of US patent 11,723,680 covering critical features of the bipolar handpiece used in Signati’s...
Signati™ Medical Files IDE Study with FDA
26 sept. 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Signati™ Medical has officially filed their IDE study with the FDA. An Investigational Device Exemption (IDE) allows the investigational device to...
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
19 sept. 2023 09h30 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
10 août 2023 09h30 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the...
Signati™️ Medical, Inc. Announces Dr. LeRoy Jones Has Been Appointed to Its Board of Directors
03 août 2023 09h00 HE
|
Signati Medical Inc.
Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed to its Board of Directors. Dr. Jones is considered an authority in...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
24 juil. 2023 09h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or Testosterone Deficiency, is proud to...
Cepham’s Prosprune Protects Men and Sustains the Environment in the Name of Prostate Health
18 juil. 2023 08h28 HE
|
Cepham
CHANDIGARH, India, July 18, 2023 (GLOBE NEWSWIRE) -- Researchers at Cepham, an innovative leader in nutraceuticals research and branded ingredients, have developed a patent-pending hydro-ethanolic...
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
09 juin 2023 10h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...